Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J4GP
|
|||
Drug Name |
Aminopyrimidine derivative 9
|
|||
Synonyms |
PMID26293650-Compound-46
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Myrexis
|
|||
Structure |
Download2D MOL |
|||
Formula |
C25H25N5O3
|
|||
Canonical SMILES |
CC(=O)NCC1=CC=C(C=C1)NC2=NC=CC(=N2)C3=CC(=C(C=C3)OC4CCOCC4)C#N
|
|||
InChI |
1S/C25H25N5O3/c1-17(31)28-16-18-2-5-21(6-3-18)29-25-27-11-8-23(30-25)19-4-7-24(20(14-19)15-26)33-22-9-12-32-13-10-22/h2-8,11,14,22H,9-10,12-13,16H2,1H3,(H,28,31)(H,27,29,30)
|
|||
InChIKey |
AZLRFMPKDVYEQH-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | NF-kappa-B-activating kinase (TBK1) | Target Info | Inhibitor | [1] |
Target's Patent Info | NF-kappa-B-activating kinase (TBK1) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.